Pharmeuropa bio
Discontinued
Publisher:
European Directorate for the Quality of Medicines,
Country: France
Language: English
Author(s):
Biological Standardisation Programme., European Directorate for the Quality of Medicines.
Start Year:2003 - 2008
Identifiers
| ISSN: | 1684-7075 (Print) 1816-8523 (Electronic) 1684-7075 (Linking) |
| NLM ID: | 101193650 |
| (OCoLC): | 55740590 |
| LCCN: | 2004243616 |
| Classification: | W1 PH1092 |
Collaborative study for the establishment of a candidate equine influenza subtype 2 American-like strain A/EQ/South Africa/4/03 – horse antiserum biological reference preparation. In 2004, the Office International des Epizooties (OIE) Expert Surveillance Panel on equine influenza recommended that the American lineage component (H3N8) of equine influenza vaccines (A/eq/Newmarket/1/93-like) be updated to an A/eq/South Africa/4/03-like virus. As a consequence the common European Pharmacopoeia (Ph. Eur.) - OIE reference for equine influenza subtype 2 American-like antiserum had to be complemented by an antiserum raised in horses against an A/eq/South Africa/4/03 strain. An international collaborative study run by the European Directorate for the Quality of Medicines (EDQM) ...
Efficacy demonstration of tetanus vaccines by double antigen ELISA. This paper describes a double antigen ELISA (DAE) for rapid, specific and reliable assessment of the antitetanus immune status of horses and sheep. Compared with the indirect ELISA, the double antigen ELISA has the advantage of species-independent testing of sera. Thanks to its test design, it is more specific since the detected antibodies are forced to bind tetanus toxoid twice. In addition, it is very sensitive to tetanus antibodies, enabling the detection of low antibody titres, in range which is relevant for the assessment of the protective status (tetanus toxin neutralising antibodies). T...